News
There’s no rest for the wicked or for chipmakers chasing Nvidia (NVDA) in the AI race. Advanced Micro Devices (AMD) is by no ...
ParaZero (PRZO) Technologies announced the launch of its latest drone safety innovation, the SafeAir M4, its next-generation autonomous parachute recovery system now fully compatible with the DJI ...
NVIDIA (NVDA) announced the NVIDIA GeForce RTX 5060 family of GPUs, including two graphics cards that deliver neural rendering and NVIDIA ...
In a report released today, Ken Worthington from J.P. Morgan maintained a Hold rating on Blackstone Group (BX – Research Report), with a price ...
Baird raised the firm’s price target on Alignment Healthcare (ALHC) to $22 from $17 and keeps an Outperform rating on the shares. The firm sees ...
The auto supply chain is vast and spans numerous countries across the world, so any tariffs would have a knock-on impact on ...
Taiwan Semiconductor Manufacturing (TSM) or TSMC, the world’s leading contract chip maker, is set to release its full ...
Bank of America (BAC), the second-largest U.S. bank, has been ordered to pay $540.3 million to the Federal Deposit Insurance ...
Cantor Fitzgerald upgraded Verve Therapeutics (VERV) to Overweight from Neutral. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your ...
Allied is a leading owner-operator of distinctive urban workspace in Canada’s major cities. Allied’s mission is to provide knowledge-based organizations with workspace that is sustainable and ...
Mizuho lowered the firm’s price target on Bill (BILL) to $53 from $70 and keeps a Neutral rating on the shares as part of a Q1 preview for the ...
TD Cowen analyst Yaron Werber maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $59.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results